Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000645

Drug Information
NameGanciclovir    
SynonymsHHEMG; BW 759; MB3795; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; CAS-82410-32-0; NCGC00015471-06; GCV & MSL; 2'-Nor-2'-deoxyguanosine; Zirgan; 82410-32-0; AC1L1FZ2; Hydroxyacyclovir; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; EU-0100539; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; Vitrasert (TN); Ganciclovirum; CHEBI:465284; Ganciclovir [USAN:INN:BAN:JAN]; 2'-NDG; DRG-0018; 107910-75-8 (mono-hydrochloride salt); AC1Q52OB; MLS001077349; Prestwick1_000839; MolPort-002-507-301; BW-B 759U; NCGC00015471-03; I07-0010; nchembio.87-comp3; Cytovene; Prestwick_1068; Ganciclovir & C34-dgA immunotoxin; 6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-; AKOS004119898; BW-795; BIDD:GT0783; Prestwick0_000839; HSDB 6512; HMS2090K08; Prestwick2_000839; Cymeven; SMR000058324; D00333; CID3454; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; Lopac-G-2536; 96551-29-0; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; STK801910; UNII-P9G3CKZ4P5; NCGC00015471-02; BW-759U; Prestwick3_000839; IN1478; ST-605; Citovirax; NCGC00015471-01; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; PDSP1_000816; Cytovene-IV; Biolf 62; DB01004; BPBio1_000877; Gancyclovir; PDSP2_000803; SAM002548936; GANCICLOVIR SODIUM; SMP2_000038; BSPBio_000797; HMS1570H19; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; G2536_SIGMA; BW 759U; G 2536; Cytovene (TN); 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; CPD000058324; NCGC00093928-01; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 106931-35-5; NCGC00093928-02; Virgan; Ganciclovirum [Latin]; Ganciclovir & D5-dgA immunotoxin; AC-12604; CHEMBL182; LS-73939; MLS000028481; Lopac0_000539; RS-21592; BB_NC-1042; 86357-12-2; ganciclovir; GA2; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; BIOLF-62; Cymevan; Ganciclovir (JAN/USP/INN); GCV & 1110U81; Cymevene; ZINC00001505; Vitrasert; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-; CCRIS 9212; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; SPBio_002718; NCGC00168567-01; MolPort-000-758-398    
Trade NameCytovene; Cymevene; Vitrasert    
CompanyBausch & Lomb Pharmaceuticals, Inc.    
IndicationVirus infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntiviral Agents    
CAS NumberCAS 82410-32-0
FormularC9H13N5O4    
PubChem Compound IDCID 3454.    
PubChem Substance IDSID 192372.    
SuperDrug ATC IDJ05AB06;    
SuperDrug CAS ID082410320;    
TargetDNA polymeraseInhibitor[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi. 2009 Feb;30(2):77-81. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543